Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, and Liver Disease and Transplantation.
Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypes
Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma.
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials
ZEB1 regulates BCL2 in cancer-associated fibroblasts to promote cholangiocarcinoma chemoresistance to gemcitabine and cisplatin
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
Primary liver cancer classification from routine tumour biopsy using weakly supervised deep learning
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival.
Clinical relevance of subtyping <i>CTNNB1</i>‐mutated hepatocellular adenomas: Different risk patterns according to the mutation type
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
EASL-ERN position paper on liver involvement in patients with Fontan-type circulation
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis.
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors
ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma.
Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis
Endothelial autophagy is not required for liver regeneration after partial hepatectomy in mice with fatty liver.
Current therapies and new developments in NASH
Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.
Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD
The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers
Differentiation of hepatocellular adenoma by subtype and hepatocellular carcinoma in non-cirrhotic liver by fractal analysis of perfusion MRI
Reply to: Correspondence regarding "Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies".
Baveno VII – Renewing consensus in portal hypertension
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
Combined hepatocellular-cholangiocarcinoma: An update.